John P. Schmid, Director of First Tracks Biotherapeutics TRAX, has filed 7 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 06/15.

JS

JS

John P. Schmid

Director

Company

First Tracks Biotherapeutics TRAX

First filing

23/01/10

Trades

89 trades

Buys / sales

7 / 3

12-month net buying

−$1.2M

Last trade

06/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AnaptysbioANAB	Open-market sale	03/30	04/01	20,645 sh3 trades	$56.11avg.	$1,158,466.86	−39.5%
Xeris Biopharma HoldingsXERS	Open-market buy	24/08/12	24/08/13	4,515 sh	$2.25	$10,158.75	+21.8%
Xeris Biopharma HoldingsXERS	Open-market buy	24/08/09	24/08/12	4,285 sh	$2.37	$10,155.45	+26.1%
Xeris Biopharma HoldingsXERS	Open-market buy	24/05/10	24/05/10	5,400 sh	$1.91	$10,314	+49.1%
Design TherapeuticsDSGN	Open-market buy	24/03/22–24/03/25	24/03/25	26,965 sh2 trades	$3.70avg.	$99,750.38	No record
Xeris Biopharma HoldingsXERS	Open-market buy	24/03/14	24/03/14	4,500 sh	$2.16	$9,720	+69.2%
Xeris Biopharma HoldingsXERS	Open-market buy	23/11/16	23/11/17	6,500 sh	$1.51	$9,815	No record